Evidence map›Paper›PMID 42409824›Full record

ArticleNature communications2026

Patterns of emergence and circulation of West Nile Virus in Algeria.

Aissam Hachid, Chahrazed Benbetka, Abderrezak Bouamra, Nesrine Bouredjoul, Fayez Ahmed Khardine, Noé Ochida, Rafik Garni, Aldjia Khaldi, Mohamed Seghier, Kelly Charniga and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Aissam Hachid *Laboratory of Arboviruses and Emerging Viruses, Institut Pasteur d'Algérie, Algiers, Algeria. ahachid@pasteur.dz.ORCID http://orcid.org/0000-0002-6311-748X
Chahrazed Benbetka *Laboratory of Arboviruses and Emerging Viruses, Institut Pasteur d'Algérie, Algiers, Algeria.ORCID http://orcid.org/0000-0003-1639-8220
Abderrezak BouamraDepartment of Epidemiology, Beni-Messous University Hospital, Algiers, Algeria.
Nesrine BouredjoulLaboratory of Arboviruses and Emerging Viruses, Institut Pasteur d'Algérie, Algiers, Algeria.
Fayez Ahmed KhardineLaboratory of Arboviruses and Emerging Viruses, Institut Pasteur d'Algérie, Algiers, Algeria.
Noé OchidaMathematical Modelling of Infectious Diseases Unit, Institut Pasteur, Université Paris Cité, INSERM U1332, CNRS UMR 2000, Paris, France.ORCID http://orcid.org/0000-0003-2347-6426
Rafik GarniDepartment of Preventive Medicine and Medical Analysis, Institut Pasteur d'Algérie, Algiers, Algeria.ORCID http://orcid.org/0000-0002-3076-4293
Aldjia KhaldiLaboratory of Arboviruses and Emerging Viruses, Institut Pasteur d'Algérie, Algiers, Algeria.
Mohamed SeghierLaboratory of Arboviruses and Emerging Viruses, Institut Pasteur d'Algérie, Algiers, Algeria.
Kelly CharnigaMathematical Modelling of Infectious Diseases Unit, Institut Pasteur, Université Paris Cité, INSERM U1332, CNRS UMR 2000, Paris, France.
Simon CauchemezMathematical Modelling of Infectious Diseases Unit, Institut Pasteur, Université Paris Cité, INSERM U1332, CNRS UMR 2000, Paris, France. simon.cauchemez@pasteur.fr.ORCID http://orcid.org/0000-0001-9186-4549

Funding

Inter-regional study of transmission, adaptation and pathogenesis of viruses with pandemic potential in Southeast Asia and West/Central AfricaU01AI151758 · NIAID · INSTITUT PASTEUR · PI SAKUNTABHAI, ANAVAJ, SIMON-LORIERE, ETIENNE · 2020 to 2024
$6.7M
Agence Nationale de la Recherche (French National Research Agency) ANR-10-LABX-62-IBEIDEC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 874735NIAID NIH HHS U01 AI151758U.S. Department of Health & Human Services | National Institutes of Health (NIH) U01AI151758
6 · The paper itself

Abstract

In recent years, many countries have experienced increased outbreaks of vector-borne diseases, such as West Nile virus (WNV). WNV is primarily transmitted to humans by the bite of infected Culex mosquitoes and has an enzoonotic transmission cycle involving birds. In Algeria, serological evidence of WNV in humans dates back to the 1970s, but circulation patterns are poorly characterized. To address this, we conduct a cross-sectional seroprevalence survey of WNV in humans and fit serocatalytic models to the data. We also analyze data on severe WNV cases. In this study, we report a seroprevalence of 16.7%. We identify age, region, and residence type as risk factors for infection. We also show that patterns of spread in two provinces in the south are consistent with low level endemic risk over decades, while those from three provinces in the north are all consistent with single outbreaks that occurred within the last 10-15 years. An outbreak may have occurred in Oran in 2010 and in Jijel and Tizi Ouzou near the time of data collection in 2017 and 2018, respectively. Investigation of potential drivers of viral establishment, along with continued surveillance of WNV cases, especially in the northern provinces, is warranted.

Indexed as

West Nile FeverWest Nile virusAlgeriaAnimalsAntibodies, ViralCross-Sectional StudiesCulexDisease OutbreaksFemaleHumansMaleMosquito-Borne DiseasesRisk FactorsSeroepidemiologic StudiesAntibodies, Viral

Identifiers

PMID42409824
PMCPMC13473090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.